Plain-English translation of NCT07256249 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is tracking real patients who receive the SELUTION sirolimus-eluting balloon — a special balloon coated with medication — to treat blocked heart arteries. The study follows you for 12 months to see how well this treatment works, whether it prevents the artery from clogging again, and whether you experience any serious heart problems.
Blocked heart arteries are a serious problem, and sometimes arteries can become blocked again even after treatment. This medication is designed to help prevent that re-blocking, and researchers want to understand how effective this treatment is in real patients under everyday conditions.
You likely qualify if…
You likely don't qualify if…
You will receive the SELUTION balloon treatment as your doctor recommends, and then the research team will follow up with you periodically over 12 months to check on your heart health. This involves visits where doctors will monitor you for any heart problems and ask about your symptoms. The study is observational, meaning the doctors are watching and recording what happens — you're not being asked to do anything extra beyond your regular care.
AI-generated summary from trial data · Jul 10, 2026 · Not medical advice
Portugal
Spain